Walleye Capital LLC Insmed Inc Call Options Transaction History

Walleye Capital LLC

  • $46.2 Billion
  • Q3 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$62.0 - $79.01 $2.7 Million - $3.44 Million
43,600 New
43,600 $3.18 Million
Q1 2023

May 15, 2023
BUY
$16.26 - $21.73 $334,956 - $447,638
20,600 New
20,600 $351,000
Q3 2019

Nov 14, 2019
SELL
$15.49 - $25.78 $340,780 - $567,160
-22,000 Closed
0 $0
Q2 2019

Aug 14, 2019
BUY
$23.0 - $32.19 $506,000 - $708,180
22,000 New
22,000 $563,000

Others Institutions Holding INSM

# of Institutions
466
Shares Held
180M
Call Options Held
2.27M
Put Options Held
3.33M
View Full List

About INSMED Inc

INSM Quotes by TradingView
  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $9.56B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track Walleye Capital LLC Portfolio

Follow Walleye Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Capital LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email